USA |NASDAQ |USD |ADR
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Aug 2, 2022 | Jun 2022 | - | $-0.23 | $-0.29 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Aug 2, 2022 | Jun 2022 | - | $0.00 | $0.00 |
Ac Immune Sa's next earnings date is Tuesday, Aug 2, 2022 for the fiscal quarter ending Jun 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 3 | $0.09 | $-0.01 | $0.19 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 0 / 0 | $0.09 | $0.10 | $-0.10 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 3 | $77.03M | $26.79M | $109.63M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Aug 2, 2022 | Jun 2022 | $-0.24 | - | - |
| Apr 28, 2022 | Mar 2022 | $-0.22 | $-0.23 | -4.55% |
| Mar 22, 2022 | Dec 2021 | $0.10 | $-0.28 | -380.00% |
| Nov 8, 2021 | Sep 2021 | $-0.30 | $-0.24 | 19.46% |
| Aug 4, 2021 | Jun 2021 | $-0.23 | $-0.29 | -25.72% |
| Apr 28, 2021 | Mar 2021 | $-0.24 | $-0.25 | -3.35% |
| Mar 23, 2021 | Dec 2020 | $-0.27 | $-0.29 | -8.20% |
| Nov 13, 2020 | Sep 2020 | $-0.27 | $-0.28 | -6.03% |
| Aug 5, 2020 | Jun 2020 | $-0.29 | $-0.24 | 15.91% |
| May 4, 2020 | Mar 2020 | $-0.14 | $-0.11 | 21.29% |
| Mar 30, 2020 | Dec 2019 | $-0.22 | $-0.29 | -30.21% |
| Nov 13, 2019 | Sep 2019 | $-0.05 | $0.25 | 634.25% |
| Aug 14, 2019 | Jun 2019 | $-0.23 | $-0.25 | -7.83% |
| May 15, 2019 | Mar 2019 | $1.33 | $0.90 | -32.32% |
| Mar 21, 2019 | Dec 2018 | $0.35 | $-0.21 | -161.06% |
| Nov 13, 2018 | Sep 2018 | $-0.22 | $-0.21 | 6.00% |
| Aug 8, 2018 | Jun 2018 | $-0.23 | $-0.19 | 15.39% |
| May 2, 2018 | Mar 2018 | $-0.20 | $-0.20 | 1.62% |
| Mar 20, 2018 | Dec 2017 | $0.02 | $0.08 | 314.36% |
| Nov 13, 2017 | Sep 2017 | $-0.13 | $-0.15 | -16.83% |
| Aug 9, 2017 | Jun 2017 | $-0.16 | $-0.23 | -38.78% |
| May 11, 2017 | Mar 2017 | $-0.17 | $-0.17 | -1.32% |
| Mar 17, 2017 | Dec 2016 | $-0.15 | $-0.09 | 41.24% |
| Nov 11, 2016 | Sep 2016 | $-0.17 | $-0.18 | -8.16% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 22, 2022 | Dec 2021 | $-0.43 | $-1.06 | - |
| Mar 23, 2021 | Dec 2020 | $-0.89 | $-0.93 | - |
| Mar 30, 2020 | Dec 2019 | $0.69 | $0.62 | -10.70% |
| Mar 21, 2019 | Dec 2018 | $-0.21 | $-0.81 | - |
| Mar 20, 2018 | Dec 2017 | $-0.59 | $-0.46 | - |
| Mar 17, 2017 | Dec 2016 | - | $-0.27 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Aug 2, 2022 | Jun 2022 | - | - | - |
| Apr 28, 2022 | Mar 2022 | - | $0.00 | - |
| Mar 22, 2022 | Dec 2021 | $39.48M | $0.00 | - |
| Nov 8, 2021 | Sep 2021 | $1.93M | $0.00 | - |
| Aug 4, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| Apr 28, 2021 | Mar 2021 | $3.64M | $0.00 | - |
| Mar 23, 2021 | Dec 2020 | $1.40M | $944.00K | 0.67% |
| Nov 13, 2020 | Sep 2020 | $930.00K | $1.12M | 1.21% |
| Aug 5, 2020 | Jun 2020 | $550.00K | $1.28M | 2.32% |
| May 4, 2020 | Mar 2020 | $13.31M | $12.41M | 0.93% |
| Mar 30, 2020 | Dec 2019 | $11.26M | $1.06M | 0.09% |
| Nov 13, 2019 | Sep 2019 | $31.43M | $33.41M | 1.06% |
| Aug 14, 2019 | Jun 2019 | $1.20M | $1.51M | 1.26% |
| May 15, 2019 | Mar 2019 | $97.25M | $75.04M | 0.77% |
| Mar 21, 2019 | Dec 2018 | $43.27M | $1.40M | 0.03% |
| Nov 13, 2018 | Sep 2018 | $850.00K | $2.31M | 2.71% |
| Aug 8, 2018 | Jun 2018 | $950.00K | $2.03M | 2.14% |
| May 2, 2018 | Mar 2018 | $2.12M | $1.46M | 0.69% |
| Mar 20, 2018 | Dec 2017 | $14.81M | $16.42M | 1.11% |
| Nov 13, 2017 | Sep 2017 | $7.81M | $1.07M | 0.14% |
| Aug 9, 2017 | Jun 2017 | $4.29M | $750.00K | 0.17% |
| May 11, 2017 | Mar 2017 | - | $2.01M | - |
| Mar 17, 2017 | Dec 2016 | - | $1.43M | - |
| Nov 11, 2016 | Sep 2016 | - | $1.33M | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 22, 2022 | Dec 2021 | $42.68M | $0.00 | - |
| Mar 23, 2021 | Dec 2020 | $16.81M | $15.43M | -8.20% |
| Mar 30, 2020 | Dec 2019 | $111.71M | $111.03M | -0.61% |
| Mar 21, 2019 | Dec 2018 | $49.08M | $7.19M | -85.34% |
| Mar 20, 2018 | Dec 2017 | $18.92M | $20.25M | 7.06% |
| Mar 17, 2017 | Dec 2016 | - | $23.21M | - |
ACIU's next earnings date is Tuesday, Aug 2, 2022 for the fiscal quarter ending Jun 30, 2022.
The average EPS estimation for Ac Immune Sa's next quarterly earnings is $-0.24.
Ac Immune Sa's previous earnings date was Apr 28, 2022 for its fiscal quarter ended Mar 31, 2022.
ACIU's earnings per share (EPS) was $-0.23, missing the consensus analysts forecast of $-0.22 by -4.55%.
The EPS was higher than the previous fiscal quarter (Dec 2021) by -17.86%, and higher than the same period a year before (Mar 2021) by -9.09%.
Revenues were $0.00.
The company reported a net income of $-18.85M.Free cash flow for the quarter was $-23.68M , compared to $-18.55M last quarter and $-18.13M a year before.
ACIU ended the quarter with $2.77M in total debt, a decrease of -4.85% compared to the previous quarter, and an increase of 28.97% compared to the same quarter a year before.
Ac Immune Sa's previous annual earnings date was Mar 22, 2022 for its fiscal year ended Dec 31, 2021.
ACIU's earnings per share (EPS) was $-1.06, missing the consensus analysts forecast of $-0.43 by 146.67% , and lower than the previous year's EPS (Dec 2020) by 14.08%.
Revenues were $0.00.
The company reported a net income of $-73.00M.
Ac Immune Sa reported a free cash flow of $-68.32M for its fiscal year, compared to $-61.22M a year ago.
The company ended the fiscal year with $2.91M in total debt, an increase of 30.90% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
